Mortality risk reduction in patients receiving antiresorptive treatment after a hip fracture

被引：0
|
作者：
Diehl, M. [1 ]
Beratarrechea, A. [1 ]
Pace, N. [1 ]
Saimovici, J. [1 ]
Trossero, A. [1 ]
Plantalech, L. [1 ]
机构：
[1] Hosp Italiano Buenos Aires, Endocrinol & Internal Med Serv, Buenos Aires, DF, Argentina
来源：
BONE | 2011年 / 49卷 / 06期
关键词：
D O I：
10.1016/j.bone.2011.09.026
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1380 / 1380
页数：1
相关论文
共 50 条
  • [21] Drug adherence and treatment duration for denosumab and mortality risk among hip fracture patients
    Yi-Lun Tsai
    Chih-Hsing Wu
    Chia-Chun Li
    Chien-An Shih
    Yin-Fan Chang
    Jawl-Shan Hwang
    Ta-Wei Tai
    Osteoporosis International, 2023, 34 : 1783 - 1791
  • [22] Atypical femoral fracture after receiving antiresorptive drugs in breast cancer patients with bone metastasis
    Ota, Seiya
    Inoue, Ryo
    Shiozaki, Takashi
    Yamamoto, Yuji
    Hashimoto, Naoki
    Takeda, On
    Yoshikawa, Kei
    Ito, Junji
    Ishibashi, Yasuyuki
    BREAST CANCER, 2017, 24 (04) : 601 - 607
  • [23] Atypical femoral fracture after receiving antiresorptive drugs in breast cancer patients with bone metastasis
    Seiya Ota
    Ryo Inoue
    Takashi Shiozaki
    Yuji Yamamoto
    Naoki Hashimoto
    On Takeda
    Kei Yoshikawa
    Junji Ito
    Yasuyuki Ishibashi
    Breast Cancer, 2017, 24 : 601 - 607
  • [24] Potential Mediators of the Reduction in Mortality with Zoledronic Acid after Hip Fracture
    Colon-Emeric, C.
    Mesenbrink, P.
    Lyles, K.
    Pieper, C.
    Boonen, S.
    Delmas, P.
    Eriksen, E.
    Magaziner, J.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S10 - S10
  • [25] Potential Mediators of the Mortality Reduction With Zoledronic Acid After Hip Fracture
    Colon-Emeric, Cathleen S.
    Mesenbrink, Peter
    Lyles, Kenneth W.
    Pieper, Carl F.
    Boonen, Steven
    Delmas, Pierre
    Eriksen, Erik F.
    Magaziner, Jay
    JOURNAL OF BONE AND MINERAL RESEARCH, 2010, 25 (01) : 91 - 97
  • [26] In-hospital mortality after hip fracture by treatment setting
    Sheehan, Katie J.
    Sobolev, Boris
    Guy, Pierre
    Kuramoto, Lisa
    Morin, Suzanne N.
    Sutherland, Jason M.
    Beaupre, Lauren
    Griesdale, Donald
    Dunbar, Michael
    Bohm, Eric
    Harvey, Edward
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2016, 188 (17-18) : 1219 - 1225
  • [27] Hip fracture risk in patients with atrial fibrillation receiving oral anticoagulants
    Sugiyama, Toshihiro
    EUROPEAN HEART JOURNAL, 2020, 41 (30) : 2918 - 2918
  • [28] MORTALITY RATE AND RISK FACTOR OF PATIENTS WITH FRAGILE HIP FRACTURE
    Sangkomkamhang, T.
    Sangkomkamhang, U. Swadpanich
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S331 - S331
  • [29] COMPREHENSIVE GERIATRIC ASSESSMENT FOR IDENTIFYING MORTALITY RISK IN OLD PATIENTS AFTER HIP FRACTURE SURGERY
    Shih, N. -C.
    Chen, K. -H.
    Lin, S. -Y.
    Lee, C. -H.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S165 - S166
  • [30] Secular reduction of excess mortality in hip fracture patients >85 years
    Trine E Finnes
    Haakon E Meyer
    Jan A Falch
    Asle W Medhus
    Tore Wentzel-Larsen
    Cathrine M Lofthus
    BMC Geriatrics, 13
12345